SE450381B - Estrar av nikotinsyra och 2-(p-klorfenoxi)-isosmorsyra till anvendning som lipidsenkande medel - Google Patents

Estrar av nikotinsyra och 2-(p-klorfenoxi)-isosmorsyra till anvendning som lipidsenkande medel

Info

Publication number
SE450381B
SE450381B SE8000962A SE8000962A SE450381B SE 450381 B SE450381 B SE 450381B SE 8000962 A SE8000962 A SE 8000962A SE 8000962 A SE8000962 A SE 8000962A SE 450381 B SE450381 B SE 450381B
Authority
SE
Sweden
Prior art keywords
nicotinate
acid addition
acid
addition salt
pharmaceutically usable
Prior art date
Application number
SE8000962A
Other languages
English (en)
Swedish (sv)
Other versions
SE8000962L (sv
Inventor
A Scherm
K Hummel
D Peteri
Original Assignee
Merz & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co filed Critical Merz & Co
Publication of SE8000962L publication Critical patent/SE8000962L/xx
Publication of SE450381B publication Critical patent/SE450381B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8000962A 1979-02-08 1980-02-06 Estrar av nikotinsyra och 2-(p-klorfenoxi)-isosmorsyra till anvendning som lipidsenkande medel SE450381B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2904757 1979-02-08

Publications (2)

Publication Number Publication Date
SE8000962L SE8000962L (sv) 1980-08-09
SE450381B true SE450381B (sv) 1987-06-22

Family

ID=6062456

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8000962A SE450381B (sv) 1979-02-08 1980-02-06 Estrar av nikotinsyra och 2-(p-klorfenoxi)-isosmorsyra till anvendning som lipidsenkande medel

Country Status (22)

Country Link
JP (1) JPS55129245A (fr)
AR (1) AR228251A1 (fr)
AT (1) AT374797B (fr)
AU (1) AU532208B2 (fr)
BE (1) BE881626A (fr)
CA (1) CA1135689A (fr)
CH (1) CH644092A5 (fr)
DK (1) DK152360C (fr)
ES (1) ES488345A0 (fr)
FR (1) FR2448532A1 (fr)
GB (1) GB2041937B (fr)
GR (1) GR73905B (fr)
HU (1) HU182099B (fr)
IE (1) IE49385B1 (fr)
IL (1) IL59337A (fr)
IT (1) IT1141197B (fr)
MX (1) MX6377E (fr)
NL (1) NL8000826A (fr)
PL (1) PL123379B1 (fr)
SE (1) SE450381B (fr)
SG (1) SG51185G (fr)
YU (1) YU33880A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3891219T1 (de) * 1988-01-22 1990-02-01 Kh Nii Endokrinologii I Chimii P-chlorphenoxysobuttersaeureundezylester und arzneimittel auf dessen grundlage zur behandlung der hyperlipidaemie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3175M (fr) * 1963-06-25 1965-03-08 Analyses Et De Rech S Biolog M Nouveaux composés chimiques a action vaso-dilatatrice périphérique.
DE2352012A1 (de) * 1972-11-01 1974-05-09 Ciba Geigy Ag Neue aliphatisch substituierte arylchalkogeno-kohlenwasserstoffderivate und verfahren zu ihrer herstellung
ES438246A1 (es) * 1975-06-04 1977-01-16 Alter Sa Un procedimiento de preparacion del glicol 2-(p-clorofenoci)-2-metilpropinato nicotinato.
JPS57102866A (en) * 1980-12-19 1982-06-26 Kyorin Pharmaceut Co Ltd Nicotinic acid derivative and its preparation

Also Published As

Publication number Publication date
CH644092A5 (de) 1984-07-13
ATA70380A (de) 1983-10-15
DK53680A (da) 1980-08-09
FR2448532A1 (fr) 1980-09-05
IE800236L (en) 1980-08-08
PL221888A1 (fr) 1980-10-20
IT1141197B (it) 1986-10-01
FR2448532B1 (fr) 1984-12-14
AT374797B (de) 1984-05-25
ES8101552A1 (es) 1980-12-16
JPS55129245A (en) 1980-10-06
PL123379B1 (en) 1982-10-30
SE8000962L (sv) 1980-08-09
AU532208B2 (en) 1983-09-22
JPS6126993B2 (fr) 1986-06-23
GB2041937A (en) 1980-09-17
BE881626A (fr) 1980-08-08
IE49385B1 (en) 1985-10-02
DK152360B (da) 1988-02-22
AU5535580A (en) 1980-08-14
GR73905B (fr) 1984-05-21
CA1135689A (fr) 1982-11-16
NL8000826A (nl) 1980-08-12
MX6377E (es) 1985-05-23
ES488345A0 (es) 1980-12-16
IL59337A (en) 1984-10-31
IT8019782A0 (it) 1980-02-08
DK152360C (da) 1988-08-01
HU182099B (en) 1983-12-28
YU33880A (en) 1983-06-30
AR228251A1 (es) 1983-02-15
SG51185G (en) 1986-01-24
GB2041937B (en) 1983-04-13

Similar Documents

Publication Publication Date Title
US6589959B1 (en) Crystalline bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid]calcium salt
US4714762A (en) Antiarteriosclerotic substituted benzimidazol-2-yl-and 3H-imidazo[4,5-b]pyridin-2-yl-phenoxy-alkanoic acids and salts and esters thereof
EP2013188B1 (fr) Sel de zinc de rosuvastatine
JPH02250870A (ja) コレステロール生合成抑制性化合物
USRE32581E (en) Certain substituted phenyl esters of nicotinic acid, compositions and methods of using same for treatment of hyperlipidemia
EP4015508A1 (fr) Procédés de préparation de 5,6-dihydro-6-phénylbenzo[f]isoquinoléine-2-amine substituée
US4218457A (en) 2-Substituted 5-hydroxy-1H-imidazole-4-carboxamide derivatives and use
WO1983003096A1 (fr) Derives d'immidazole
JPS6341462A (ja) 1−ヒドロキシ−2−ピリドンの製造法
US4681890A (en) 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same
EP0074628B1 (fr) Dérivés de l'ascochlorin, procédé pour leur préparation et compositions pharmaceutiques les contenant
EP0132994B1 (fr) Composés pour abaisser le taux de lipides
EP0166302A2 (fr) 1-[Bis-(4-fluorophényl)méthyl]-4-(3-phényl-2-propényl)-hexahydro-1H-1,4-diazépine, sa préparation et composition la contenant
SE450381B (sv) Estrar av nikotinsyra och 2-(p-klorfenoxi)-isosmorsyra till anvendning som lipidsenkande medel
CS221810B2 (en) Method of making the new isochinoline derivatives with contanets of sulphur
US3980646A (en) 3-Methylpyrazole-5-carboxylates and medicaments containing these compounds
EP1686990B1 (fr) Composes de 2-guanidinylimidazolidinedione: procedes de preparation et d'utilisation
US4677105A (en) 2-alkoxycarbonylalkyl-3-oxo-5,6-diaryl-as-triazines having utility as therapeutics
US20040053967A1 (en) 3-(3-Amidinophenyl)-5-[({[1-(1-(iminoethyl)-4-piperidyl}amino)methyl]benzoic acid dihydrochloride and process for preparing the same
EP0122376B1 (fr) Dérivés de la pyridine doués d'une activité anticholinestérase
EP0391796A1 (fr) Dérivés de l'imidazole, procédé pour leur préparation et compositions pharmaceutiques les contenant
EP0254167B1 (fr) Esters de l'acide hydroxy-1 oxo-5 5H-pyrido[3,2-a] phénoxazine carboxylique-3
US3801578A (en) 7-(2-hydroxy-3-(n-methyl-2-hydroxy-ethylamino)-propyl)-theophylline-2-(4-chlorophenoxy)-isobutyrate
EP0071682B1 (fr) Esters d'acide anthranilique à activité anti-inflammatoire, et leur préparation
JPS62148476A (ja) チアジアゾ−ル抗ウイルス剤

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8000962-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8000962-4

Format of ref document f/p: F